Twogee Biotech Secures €2.2 Million Seed Funding to Industrialize Circular Biomass Value Creation

• Twogee Biotech secures more than €2 million in seed funding to commercialize its enzyme platform for the industrial utilization of biomass residual streams, transforming the chemical industry through circular economy principles and sustainable building blocks.
• Founded in 2024 in Munich, Twogee develops customized enzyme solutions and corresponding production strains from lab scale to industrial manufacturing. First MVPs are available, pilot projects with industry partners are underway, and in-house laboratories and bioreactors have been established.
• Benefit for industry partners: Fossil- and food-based raw materials can be replaced by locally produced, low-CO₂ alternatives such as second-generation (2G) sugars, enabling new circular value chains from previously underutilized biomass side streams.

Twogee Biotech, a Munich-based biotechnology startup specializing in tailor-made enzyme solutions for the industrial conversion of biomass into sustainable raw materials, has successfully closed a seed financing round of €2.16 million. Investors include High-Tech Gründerfonds (HTGF) and Bayern Kapital, as well as strategic partners such as AgriFoodTech Venture Alliance and Heinz Entsorgung.

Twogee Biotech enables industrial partners to economically convert previously low-value biomass residues and by-products into sustainable second-generation (2G) raw materials (residue-based, in contrast to first-generation (1G), food-based), with a particular focus on sugars for bio- and synthetic biology applications. This is powered by a predictive development platform that integrates enzyme screening, strain engineering, and fermentation with an industrial mindset from the outset, shortening development cycles and reducing scale-up risks.

Founded in 2024 by Frank Wallrapp and Helge Jochens, each bringing more than ten years of shared industry experience in biotechnology, and supported by the Bio^M MAxL Incubator, the company is using the newly raised capital to accelerate the development and commercialization of its technology. Initial MVPs and paid pilot projects with industrial partners have already been completed. A licensing model that also enables local enzyme production at the customer site reduces costs and CO₂ emissions while supporting the creation of decentralized, circular value chains.

“Many industrial residual streams contain significant untapped commercial value,” says Frank Wallrapp, CEO of Twogee Biotech. “We help our partners unlock this potential with minimal integration effort and a clear economic value proposition.”

Helge Jochens, CTO and co-founder, adds: “A substantial portion of the funding will be invested in expanding our new laboratories at the IZB with predictive bioreactor systems, as well as strengthening our team with experienced process and scale-up experts. This ensures that our developments can be reliably and economically transferred to our customers’ production scale.”

With the successful completion of its seed financing, Twogee Biotech positions itself as a technology development partner for industrial companies seeking to transform existing facilities and material streams into circular, low-CO₂ value creation systems.

Tilmann Petersen, Investment Manager at HTGF, comments: “At HTGF, we are very proud to invest in Twogee Biotech. With its customer specific enzyme technology, Twogee is building a true enabler of the circular economy that allows many downstream industries to finally unlock long awaited growth potential. Second generation raw materials have the potential to become a real game changer when sustainability and higher profitability go hand in hand, as they do here.”

Monika Steger, Managing Director of Bayern Kapital, adds: “Twogee Biotech combines industrial biotechnology with a clear contribution to the circular economy by economically converting biological residues and by-products into high-value second-generation raw materials using customized enzyme solutions. This approach strengthens our life sciences and biotech portfolio in the field of white biotechnology by integrating resource efficiency, sustainability, and industrial scalability in a compelling way. We see significant potential and look forward to supporting the company on its growth journey.”

---

About Twogee Biotech
Twogee Biotech is a biotechnology company founded in 2024 and headquartered in Martinsried, Munich. Based on their innovative platform, the company develops customized enzyme and strain solutions for the industrial conversion of biogenic side and residual streams into sustainable second-generation raw materials. Twogee enables efficient utilization of biomass residues and supports the chemical industry in transitioning toward circular, low-CO₂ value creation—economically, scalably, and customer-focused.

For more information, visit twogee-biotech.com or follow Twogee Biotech on LinkedIn.

Media contact
Twogee Biotech GmbH
Frank Wallrapp, CEO
T.: +49 (0) 176 99389763
frank.wallrapp@twogee-biotech.com

About Bayern Kapital
Bayern Kapital is one of the most experienced and financially strong venture capital investors in the DACH region. With around €1.3 billion in assets under management, over 120 active portfolio companies, and ticket sizes of up to €50 million per company, Bayern Kapital is one of the few investors in the market that provides financing from pre-seed to global growth and scale-up rounds from a single source. As a public venture capital investor, Bayern Kapital invests in consortiums with leading national and international venture capital funds and supports tech startups and scaleups as a reliable anchor investor across multiple financing rounds.

Since 1995, Bayern Kapital has financed around 390 startups and scaleups with over €675 million of its own equity capital in areas such as deep tech, life sciences, AI, climate tech, SaaS, new space, and quantum technology. Among the numerous success stories from Bavaria are EGYM, plancq, Isar Aerospace, Tubulis, Marvel Fusion, and OroraTech.

About HTGF – High-Tech Gründerfonds
HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing startups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports startups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds. Since its inception in 2005, HTGF has financed around 800 startups and achieved 200 successful exits. HTGF has a fund volume of over 2 billion euros.

Fund investors in the public-private partnership include the Federal Ministry for Economic Affairs  and Energy, KfW Capital as well as 45 companies and family offices. For more information, please visit HTGF.de or follow us on LinkedIn.

Media contact
High-Tech Gründerfonds Management GmbH
Tobias Jacob, Senior Marketing & Communications Manager
T.: +49 228 – 82300 – 121
t.jacob@htgf.de

About AgriFoodTech Venture Alliance
The AgriFoodTech Venture Alliance is an impact-driven strategic investment vehicle founded by BayWa AG, the Bindewald + Gutting Milling Group, and the MULTIVAC Group. We invest in innovative AgriFood startups across the entire food and agriculture value chain to advance sustainable “good food” solutions for a livable future. Through strategic partnerships and guided by United Nations sustainability goals, we aim to drive positive change in the food industry while delivering measurable returns for our stakeholders.

About HEINZ Gruppe
The HEINZ Group is a family-run company based in Moosburg and has been active in the fields of waste disposal, recycling, transport, and logistics for over 90 years. As a service provider with strong regional roots in the circular economy, HEINZ combines many years of experience with a clear vision of the future. In addition to continuous investment in sustainable infrastructure and modern recycling solutions, the HEINZ Group is specifically involved in start-ups in order to gain early access to innovative technologies and new approaches in the field of recycling and resource efficiency. The aim is to actively contribute to the further development of sustainable solutions and to help shape the transformation of the circular economy in the long term.